Robotic synthesis of 6-[18F]fluoro-L-dopa

被引:14
作者
Chang, CW [1 ]
Wang, HE [1 ]
Lin, HM [1 ]
Chtsai, CS [1 ]
Chen, JB [1 ]
Liu, RS [1 ]
机构
[1] Taipei Vet Gen Hosp, Dept Nucl Med, Natl PET Cyclotron Ctr, Taipei 112, Taiwan
关键词
D O I
10.1097/00006231-200009000-00003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to develop a method of semi-automated 6-[F-18]fluoro-L-dopa (6-[F-18]FDOPA) synthesis using a robotic system (Scanditronix Anatech RE III, Uppsala, Sweden). [F-18]Fluorine was produced via Ne-20(d,alpha)F-18 using a Scanditronix MC17F cyclotron (Uppsala). The radiosynthesis was performed by the Scanditronix Anatech RE III robotic system. On average, a typical run produced 16-19 mCi of 6-[F-18]FDOPA at end of synthesis (EOS) after 2 h irradiation of the F-2/neon gas target. The total synthesis time was 110 min. The retention time of 6-[F-18]FDOPA (the radio peak) was 8.2 min, which was consistent with the 6-[F-19]FDOPA ultraviolet peak. The radiochemical purity was greater than 97%. A robotic, semi-automated method for 6-[F-18]FDOPA radiosynthesis is therefore feasible. The radiation burden for the operator can be reduced as much as possible. Sufficient activity of 6-[F-18]FDOPA could be obtained for positron emission tomography studies of dopaminergic function. (C) 2000 Lippincott William & Wilkins).
引用
收藏
页码:799 / 802
页数:4
相关论文
共 11 条
[1]  
ADAM MJ, 1986, APPL RADIAT ISOTOPES, V37, P877
[2]  
ADAM MJ, 1986, J NUCL MED, V27, P1462
[3]  
CHIRAKAL R, 1986, J NUCL MED, V27, P417
[4]  
CHIRAKAL R, 1984, INT J APPL RADIAT IS, V25, P651
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]  
DIKSIC M, 1985, J NUCL MED, V26, P1314
[7]  
FIRNAU G, 1984, J NUCL MED, V25, P1228
[8]  
KUNG HF, 1993, NEUROTRANSMISSION, V6, P1
[9]  
LUXEN A, 1990, APPL RADIAT ISOTOPES, V41, P275
[10]  
NAMAVARI M, 1992, APPL RADIAT ISOTOPES, V43, P989